Skip to content

Drug interactions

Bevacizumab + Daunorubicin

Severity: Moderate

Bevacizumab and Daunorubicin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Daunorubicin is cardiotoxic, and bevacizumab can cause hypertension and, less commonly, heart failure. Combined use may increase cardiac risk, particularly in patients with prior anthracycline exposure.

What this interaction means in plain words

Bevacizumab and Daunorubicin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Bevacizumab belongs to Oncology; Daunorubicin belongs to Oncology.

Evidence level: Low

Why it happens

Additive cardiotoxicity from anthracycline myocardial injury and VEGF inhibition-related hypertension and cardiac stress.

What to do

Assess left ventricular function before and during treatment and monitor blood pressure. Treat hypertension promptly and stop therapy if heart failure develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bevacizumab and Daunorubicin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Bevacizumab with Daunorubicin?

MediHelp rates the interaction as moderate. Bevacizumab and Daunorubicin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Daunorubicin is cardiotoxic, and bevacizumab can cause hypertension and, less commonly, heart failure. Combined use may increase cardiac risk, particularly in patients with prior anthracycline exposure.

How serious is the interaction between Bevacizumab and Daunorubicin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Assess left ventricular function before and during treatment and monitor blood pressure. Treat hypertension promptly and stop therapy if heart failure develops.

What other medicines interact with Daunorubicin?

MediHelp also lists interactions of Daunorubicin with, for example, Adenovirus types 4 and 7 live, Belatacept, Cyclosporine. The full list is on the Daunorubicin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in